Article
Generation of a human iPSC line from a Bardet-Biedl syndrome patient compound heterozygous for the BBS7 variants c.849 + 1G > C/c.754G > A.
Stem cell research - 1 Jul 2021
Fu Qian, Wang Hui, Zhou Nan, Jiang Yeping, Liang Ying, Duan Fan, Mi Lan
Abstract excerpt
Bardet-Biedl syndrome (BBS) is primarily a multisystem nonmotile ciliopathy. In this study, we describe the successful establishment and characterization of an iPSC line from a patient diagnosed with BBS who was compound heterozygous for the BBS7 variants c.849 + 1G > C (splicing) and c.754G > A (p.D252N).
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
